» Articles » PMID: 35272284

Role of Blood Pressure Responses to Exercise and Vascular Insulin Sensitivity with Nocturnal Blood Pressure Dipping in Metabolic Syndrome

Overview
Journal J Vasc Res
Date 2022 Mar 10
PMID 35272284
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Nocturnal systolic blood pressure (SBP) dipping is independently related to cardiovascular disease risk, but it is unclear if vascular insulin sensitivity associates with SBP dipping in patients with metabolic syndrome (MetS).

Methods: Eighteen adults with MetS (ATP III criteria 3.3 ± 0.6; 53.2 ± 6.5 years; body mass index 35.8 ± 4.5 kg/m2) were categorized as "dippers" (≥10% change in SBP; n = 4 F/3 M) or "non-dippers" (<10%; n = 9 F/2 M). Twenty-four-hour ambulatory blood pressure was recorded to assess SBP dipping. A euglycemic-hyperinsulinemic clamp (40 mU/m2/min, 90 mg/dL) with ultrasound (flow mediated dilation) was performed to test vascular insulin sensitivity. A graded, incremental exercise test was conducted to estimate sympathetic activity. Heart rate (HR) recovery after exercise was then used to determine parasympathetic activity. Metabolic panels and body composition (DXA) were also tested.

Results: Dippers had greater drops in SBP (16.63 ± 5.2 vs. 1.83 ± 5.6%, p < 0.01) and experienced an attenuated rise in both SBPslope (4.7 ± 2.3 vs. 7.2 ± 2.5 mm Hg/min, p = 0.05) and HRslope to the incremental exercise test compared to non-dippers (6.5 ± 0.9 vs. 8.2 ± 1.7 bpm/min, p = 0.03). SBP dipping correlated with higher insulin-stimulated flow-mediated dilation (r = 0.52, p = 0.03), although the relationship was no longer significant after covarying for HRslope (r = 0.42, p = 0.09).

Conclusion: Attenuated rises in blood pressure and HR to exercise appear to play a larger role than vascular insulin sensitivity in SBP dipping in adults with MetS.

Citing Articles

Blood Pressure Patterns and Hepatosteatosis: Cardiometabolic Risk Assessment in Dipper and Non-Dipper Phenotypes.

Astan R, Patoulias D, Ninic A, Dayanan R, Karakasis P, Mercantepe T J Clin Med. 2024; 13(22).

PMID: 39598120 PMC: 11594692. DOI: 10.3390/jcm13226976.

References
1.
DeFronzo R . The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981; 21(3):165-71. DOI: 10.1007/BF00252649. View

2.
Oh S, Han K, Han S, Koo H, Kim S, Chin H . Association of Sodium Excretion With Metabolic Syndrome, Insulin Resistance, and Body Fat. Medicine (Baltimore). 2015; 94(39):e1650. PMC: 4616840. DOI: 10.1097/MD.0000000000001650. View

3.
Mahmoud A, Szczurek M, Blackburn B, Mey J, Chen Z, Robinson A . Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles. Physiol Rep. 2016; 4(16). PMC: 5002909. DOI: 10.14814/phy2.12895. View

4.
Sartori C, Lepori M, Scherrer U . Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. Pharmacol Ther. 2005; 106(2):209-20. DOI: 10.1016/j.pharmthera.2004.11.009. View

5.
Trevisan R, Fioretto P, Semplicini A, Opocher G, Mantero F, Rocco S . Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes. 1990; 39(3):289-98. DOI: 10.2337/diab.39.3.289. View